(NewsNation) — A new study claims Ozempic may be able to reduce the risk of Alzheimer’s.
Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can benefit someone’s health from losing weight to even drug addiction.
The latest study by the Case Western Reserve University claims that out of the nearly 1 million people living with type 2 diabetes, those who were taking semaglutide — the active ingredient in Ozempic — had about a 40-70% reduction in the first-time diagnosis of Alzheimer’s.
Cardiologist and NewsNation medical contributor Dr. Dave Montgomery said this American study is interesting because it’s showing promise when about seven million people suffer from Alzheimer’s and the medical community still doesn’t have a cure for it.
Semaglutide, brain connection
Montgomery explained that the early, pre-clinical basic science research suggests that semaglutide can urge the body to destroy the hallmark of Alzheimer’s dementia, which is the tangles and plaques that form within the brain that cause it to dysfunction.
“It’s really interesting because it’s actually showing up in this study to not just treat Alzheimer’s, but prevent it. That’s really key,” Montgomery told NewsNation’s Markie Martin on “Morning in America” on Friday.
